Quick Answer
Neurogene Inc. reported Operating Income of -$103.33 million for fiscal year 2025.
Neurogene Inc. Operating Income — Annual History
| Fiscal Year | Operating Income | YoY Change |
|---|---|---|
| 2025 | -$103.33M | -25.1% |
| 2024 | -$82.61M | -48.6% |
| 2023 | -$55.58M | +1.7% |
| 2022 | -$56.52M | +6.9% |
| 2021 | -$60.70M | -80.0% |
| 2020 | -$33.73M | +52.5% |
| 2019 | -$70.96M | -117.5% |
| 2018 | -$32.62M | +36.2% |
| 2017 | -$51.12M | -35.8% |
| 2016 | -$37.65M | — |
Quarterly Operating Income
| Quarter Ending | Operating Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$23.80M | -7.3% | +8.8% |
| June 30, 2025 | -$26.08M | -29.5% | -0.6% |
| March 31, 2025 | -$25.92M | -38.0% | -16.9% |
| September 30, 2024 | -$22.18M | -45.7% | -10.2% |
| June 30, 2024 | -$20.13M | -59.8% | -7.2% |
| March 31, 2024 | -$18.78M | -44.1% | -23.4% |
| September 30, 2023 | -$15.22M | -11.8% | -20.8% |
| June 30, 2023 | -$12.60M | +20.6% | +3.4% |
- Neurogene Inc. showed a decrease of -25.1% in Operating Income compared to the prior fiscal year.
- Over the 2016–2025 period, Neurogene Inc.’s operating income has declined by 174.5% (from -$37.65 million to -$103.33 million).
- The most recent figure is from Neurogene Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: